Literature DB >> 16009701

HCV genotype 2 as a risk factor for reactivation of chronic HCV infection.

N Coppola, L M Vatiero, E Sagnelli.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16009701      PMCID： PMC1774891          DOI： 10.1136/gut.2005.070649

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  5 in total

1.  Acute exacerbations in chronic hepatitis C: a clinicopathological and prognostic study.

Authors:  I S Sheen; Y F Liaw; D Y Lin; C M Chu
Journal:  J Hepatol       Date:  1996-05       Impact factor: 25.083

2.  Diagnosis of hepatitis C virus related acute hepatitis by serial determination of IgM anti-HCV titres.

Authors:  Evangelista Sagnelli; Nicola Coppola; Cecilia Marrocco; Giancarlo Coviello; Martina Battaglia; Vincenzo Messina; Giovanni Rossi; Caterina Sagnelli; Carlo Scolastico; Pietro Filippini
Journal:  J Hepatol       Date:  2005-05       Impact factor: 25.083

3.  Progressive hepatic fibrosis in healthy carriers of hepatitis C virus with a transaminase breakthrough.

Authors:  M G Rumi; F De Filippi; M F Donato; E Del Ninno; M Colombo
Journal:  J Viral Hepat       Date:  2002-01       Impact factor: 3.728

4.  Mixed infections of hepatitis C virus as a factor in acute exacerbations of chronic type C hepatitis.

Authors:  J H Kao; P J Chen; M Y Lai; P M Yang; J C Sheu; T H Wang; D S Chen
Journal:  J Infect Dis       Date:  1994-11       Impact factor: 5.226

5.  Frequent reinfection and reactivation of hepatitis C virus genotypes in multitransfused hemophiliacs.

Authors:  L M Jarvis; H G Watson; F McOmish; J F Peutherer; C A Ludlam; P Simmonds
Journal:  J Infect Dis       Date:  1994-10       Impact factor: 5.226
  5 in total
  8 in total

Review 1.  Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals.

Authors:  Nicola Coppola; Mariantonietta Pisaturo; Rosa Zampino; Margherita Macera; Caterina Sagnelli; Evangelista Sagnelli
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

Review 2.  Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment.

Authors:  E Sagnelli; T Santantonio; N Coppola; M Fasano; M Pisaturo; C Sagnelli
Journal:  Infection       Date:  2014-03-12       Impact factor: 3.553

3.  Treatment of chronic hepatitis C genotype 3 with Sofosbuvir-based therpy: a real-life study.

Authors:  Sandeep Singh Sidhu; Nirmaljeet Singh Malhi; Omesh Goyal; Rupinder Singh; Usha Dutta; Rajiv Grover; J S Sidhu; Vijay Nanda; Harmeet Saluja; Ajesh Bansal; Gursewak Singh; Alok Sehgal; Harsh Kishore; Simran Sidhu
Journal:  Hepatol Int       Date:  2017-03-31       Impact factor: 6.047

4.  Role of genetic polymorphisms in hepatitis C virus chronic infection.

Authors:  Nicola Coppola; Mariantonietta Pisaturo; Caterina Sagnelli; Lorenzo Onorato; Evangelista Sagnelli
Journal:  World J Clin Cases       Date:  2015-09-16       Impact factor: 1.337

Review 5.  Role of occult hepatitis B virus infection in chronic hepatitis C.

Authors:  Nicola Coppola; Lorenzo Onorato; Mariantonietta Pisaturo; Margherita Macera; Caterina Sagnelli; Salvatore Martini; Evangelista Sagnelli
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

6.  The evolution of the major hepatitis C genotypes correlates with clinical response to interferon therapy.

Authors:  Phillip S Pang; Paul J Planet; Jeffrey S Glenn
Journal:  PLoS One       Date:  2009-08-11       Impact factor: 3.240

Review 7.  Hepatic flares in chronic hepatitis C: spontaneous exacerbation vs hepatotropic viruses superinfection.

Authors:  Evangelista Sagnelli; Caterina Sagnelli; Mariantonietta Pisaturo; Nicola Coppola
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

8.  Virological and epitope evolution of HCV infection from acute hepatitis C to subsequent episodes of HCV-related acute liver cell necrosis.

Authors:  E Sagnelli; C Argentini; D Genovese; M Pisaturo; N Coppola; S Taffon; C Sagnelli; M Rapicetta
Journal:  Infection       Date:  2009-07-27       Impact factor: 3.553
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.